These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 31717449)

  • 1. Influencers on Thyroid Cancer Onset: Molecular Genetic Basis.
    Luzón-Toro B; Fernández RM; Villalba-Benito L; Torroglosa A; Antiñolo G; Borrego S
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31717449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of molecular testing in thyroid tumors].
    Kachko VA; Platonova NM; Vanushko VE; Shifman BM
    Probl Endokrinol (Mosk); 2020 Sep; 66(3):33-46. PubMed ID: 33351337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNA in thyroid cancer - Functions and mechanisms.
    Cao J; Zhang M; Zhang L; Lou J; Zhou F; Fang M
    Cancer Lett; 2021 Jan; 496():117-126. PubMed ID: 32949678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyroid cancer in children and adolescents and its molecular genetic background].
    Bendlová B; Sýkorová V; Václavíková E; Včelák J; Katra R; Sýkorová P; Vlček P; Dvořáková Š
    Vnitr Lek; 2016; 62(9 Suppl 3):40-44. PubMed ID: 27734690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid paraganglioma: A case-based systematic review of literature.
    Mishra P; Padhi S; Behera G
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S11-S21. PubMed ID: 33380646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and epigenomic profile of thyroid cancer.
    Acuña-Ruiz A; Carrasco-López C; Santisteban P
    Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101656. PubMed ID: 35461756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.
    Jendrzejewski J; Thomas A; Liyanarachchi S; Eiterman A; Tomsic J; He H; Radomska HS; Li W; Nagy R; Sworczak K; de la Chapelle A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1370-7. PubMed ID: 26274343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights in Thyroid Cancer and p53 Family Proteins.
    Manzella L; Stella S; Pennisi MS; Tirrò E; Massimino M; Romano C; Puma A; Tavarelli M; Vigneri P
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.
    Sun W; Lan X; Wang Z; Dong W; He L; Zhang T; Zhang H
    Med Oncol; 2016 Sep; 33(9):102. PubMed ID: 27510368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer.
    Yi HS; Chang JY; Kim KS; Shong M
    Korean J Intern Med; 2017 Sep; 32(5):780-789. PubMed ID: 28823142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring noncoding RNAs in thyroid cancer using a graph convolutional network approach.
    Xu H; Hu X; Yan X; Zhong W; Yin D; Gai Y
    Comput Biol Med; 2022 Jun; 145():105447. PubMed ID: 35430557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of RET receptor tyrosine kinase and non-coding RNAs in MTC.
    Joo LJS; Zhao JT; Gild ML; Glover AR; Sidhu SB
    Mol Cell Endocrinol; 2018 Jul; 469():48-53. PubMed ID: 28315378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Coding RNAs in Thyroid Cancer.
    Zhang R; Hardin H; Chen J; Guo Z; Lloyd RV
    Endocr Pathol; 2016 Mar; 27(1):12-20. PubMed ID: 26847830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs in thyroid cancer: Biological functions and clinical significance.
    Sui F; Ji M; Hou P
    Mol Cell Endocrinol; 2018 Jul; 469():11-22. PubMed ID: 28751134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs in thyroid cancer.
    Sedaghati M; Kebebew E
    Curr Opin Endocrinol Diabetes Obes; 2019 Oct; 26(5):275-281. PubMed ID: 31385810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic biomarkers in thyroid cancer.
    Soares P; Celestino R; Melo M; Fonseca E; Sobrinho-Simões M
    Virchows Arch; 2014 Mar; 464(3):333-46. PubMed ID: 24487783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.
    Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY
    J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.
    Jendrzejewski J; He H; Radomska HS; Li W; Tomsic J; Liyanarachchi S; Davuluri RV; Nagy R; de la Chapelle A
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8646-51. PubMed ID: 22586128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice.
    Pringle DR; Vasko VV; Yu L; Manchanda PK; Lee AA; Zhang X; Kirschner JM; Parlow AF; Saji M; Jarjoura D; Ringel MD; La Perle KM; Kirschner LS
    J Clin Endocrinol Metab; 2014 May; 99(5):E804-12. PubMed ID: 24512487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs in endocrine malignancy.
    Kentwell J; Gundara JS; Sidhu SB
    Oncologist; 2014 May; 19(5):483-91. PubMed ID: 24718512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.